Skip to main content
Premium Trial:

Request an Annual Quote

Natera, Brazilian Hospital Ink Deal for Panorama Test

NEW YORK (GenomeWeb News) – Natera announced a deal with Hospital Israelita Albert Einstein in São Paulo to offer Natera's Panorama non-invasive prenatal test.

Financial and other terms of the deal were not disclosed.

"This test enables us to provide expecting parents with reliable information about the genetics of their baby early on in pregnancy," the hospital's Director of Maternal Fetal Medicine, Rita Sanchez, said in a statement.

Using a blood draw, Panorama examines cell-free DNA found in maternal blood and detects for trisomy 21, 18, and 13, as well as for monosomy X, triploidy, and vanishing twins.

Last week, the San Carlos, Calif.-based firm said that Panorama, along with similar tests from Illumina's Verinata Health and Ariosa Diagnostics, are being offered through the California Prenatal Screening Program. In recent months, Natera also announced distribution deals with Solstas Lab Partners and LifeLabs.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.